Tango Therapeutics Inc (TNGX)

Dec 21, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $580,000 Holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Dec 21, 2024

Dec 17, 2024

The Manufacturers Life Insurance Company Cuts Holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Dec 17, 2024

Dec 14, 2024

Tango Therapeutics' SWOT analysis: stock outlook amid PRMT5 progress, pipeline shifts - Investing.com India

Dec 14, 2024

Dec 14, 2024

Tango Therapeutics' SWOT analysis: stock outlook amid PRMT5 progress, pipeline shifts By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 13, 2024

TNGX Stock Hits 52-Week Low at $2.7 Amid Market Challenges - Investing.com UK

Dec 13, 2024

Dec 10, 2024

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Dec 10, 2024

Dec 07, 2024

Cantor Fitzgerald Reaffirms Overweight Rating for Tango Therapeutics (NASDAQ:TNGX) - Defense World

Dec 07, 2024

Dec 05, 2024

Adaptive Biotechnologies Corp (ADPT) With A Potential Upside Of More Than -193.16% - Stocks Register

Dec 05, 2024

Dec 05, 2024

Unveiling 5 Analyst Insights On Tango Therapeutics - Benzinga

Dec 05, 2024

Dec 05, 2024

Is Tango Therapeutics (NASDAQ:TNGX) In A Good Position To Invest In Growth? - Simply Wall St

Dec 05, 2024

Dec 03, 2024

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Dec 03, 2024

Dec 03, 2024

Tango Therapeutics Issues 218,750 Shares in Employee Equity Compensation Package - StockTitan

Dec 03, 2024

Nov 29, 2024

Short Interest in Tango Therapeutics, Inc. (NASDAQ:TNGX) Decreases By 21.7% - MarketBeat

Nov 29, 2024

Nov 27, 2024

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire

Nov 27, 2024

Nov 23, 2024

Tango Therapeutics Inc. (TNGX): Among the Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey

Nov 23, 2024

Nov 19, 2024

Tango Therapeutics director Mace Rothenberg acquires $74,000 in stock By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 18, 2024

Tango Therapeutics director Mace Rothenberg acquires $74,000 in stock - Investing.com

Nov 18, 2024

Nov 17, 2024

Trv Gp Iv LLC Cuts Holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Nov 15, 2024

Nov 15, 2024

B. Riley Increases Earnings Estimates for Tango Therapeutics - Defense World

Nov 15, 2024

Nov 14, 2024

B. Riley Forecasts Higher Earnings for Tango Therapeutics - MarketBeat

Nov 14, 2024

Nov 14, 2024

B. Riley Cuts Tango Therapeutics (NASDAQ:TNGX) Price Target to $8.00 - Defense World

Nov 14, 2024

Nov 13, 2024

Tango Therapeutics' SWOT analysis: stock outlook amid PRMT5 inhibitor progress - Investing.com

Nov 13, 2024

Nov 12, 2024

Tango Therapeutics (NASDAQ:TNGX) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 12, 2024

Nov 11, 2024

The Analyst Landscape: 5 Takes On Tango Therapeutics - Benzinga

Nov 11, 2024

Nov 11, 2024

B. Riley Has Lowered Expectations for Tango Therapeutics (NASDAQ:TNGX) Stock Price - MarketBeat

Nov 11, 2024

Nov 11, 2024

FY2024 Earnings Forecast for TNGX Issued By Leerink Partnrs - Defense World

Nov 11, 2024

Nov 11, 2024

Leerink Partnrs Brokers Increase Earnings Estimates for TNGX - MarketBeat

Nov 11, 2024

Nov 09, 2024

EcoR1 Capital sells $8.4 million in Tango Therapeutics stock - Investing.com India

Nov 09, 2024

Nov 09, 2024

EcoR1 Capital sells $8.4 million in Tango Therapeutics stock By Investing.com - Investing.com Australia

Nov 09, 2024

Nov 09, 2024

Tango Therapeutics' (TNGX) Buy Rating Reiterated at HC Wainwright - MarketBeat

Nov 09, 2024

Nov 09, 2024

EcoR1 Capital, LLC Adjusts Stake in Tango Therapeutics Inc - GuruFocus.com

Nov 09, 2024

Nov 09, 2024

Wedbush Has Pessimistic Outlook of TNGX FY2024 Earnings - Defense World

Nov 09, 2024

Nov 08, 2024

Wedbush Forecasts Reduced Earnings for Tango Therapeutics - MarketBeat

Nov 08, 2024

Nov 08, 2024

Tango Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 08, 2024

Nov 07, 2024

Tango Therapeutics sees $9.67m stock sale by Boxer Capital - Investing.com Nigeria

Nov 07, 2024

Nov 07, 2024

Tango Therapeutics (NASDAQ:TNGX) Price Target Lowered to $8.00 at Guggenheim - MarketBeat

Nov 07, 2024

Nov 07, 2024

Tango Therapeutics Advances Cancer Treatment Pipeline - TipRanks

Nov 07, 2024

Nov 06, 2024

Two to Tango: Brain cancer drugs go further into development - BioWorld Online

Nov 06, 2024

Nov 06, 2024

Tango stock plunges 28% amid pipeline updates, Q3 earnings report - MSN

Nov 06, 2024

Nov 06, 2024

Tango stock plunges 28% amid pipeline updates, Q3 earnings report (NASDAQ:TNGX) - Seeking Alpha

Nov 06, 2024

Nov 06, 2024

U.S. Stock market: Sunnova energy(-42.35%0, Zoomcar(-38.48%), Tango therapeutics(-27.22%) among stock losers during early trading - Business Upturn

Nov 06, 2024

Nov 06, 2024

Tango Shares Plunge After 3Q Loss, Product Plans - MarketWatch

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics advances cancer drug into full development By Investing.com - Investing.com Canada

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program - BioSpace

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024

Nov 06, 2024

Tango Therapeutics advances cancer drug into full development - Investing.com

Nov 06, 2024